News
13hon MSN
Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...
5h
The Brighterside of News on MSNFirst head-to-head trial compares tirzepatide and semaglutide - Results are in!Over the past few years, a new class of injectable medications has changed the way obesity is treated. Two drugs—tirzepatide ...
Much has been learned about GLP-1s over many years, but little is understood about why the degree of response to them varies ...
AbbVie's $10.1 billion takeover of ImmunoGen has been rewarded with EU approval for Elahere, the first drug specifically cleared ... R&D strategy as it faces the loss of revenues caused by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results